Home » Newsletters » BioWorld Science

BioWorld Science

May 21, 2012

View Archived Issues

Data reported on effects of HSC gene therapy for metachromatic leukodystrophy

Sonic hedgehog pathway inhibitors disclosed by U.S. researchers

Teva Pharmaceutical Industries patents novel compounds for MS

Novel histone deacetylase inhibitors prepared by Georgia Tech Research Corp.

Promising results reported for first patients in phase I trial of VRX-007

In vivo studies show new therapeutic potential for CDDO-Me

Daclatasvir shows promise in difficult-to-treat populations

Alisporivir results in hepatitis C virus genotypes 1, 2 and 3 reported

Novel protease inhibitors for HIV patented

Monash University presents new antimicrobial peptides

Merz Pharma designs novel cognition-enhancing drugs

Novel AMPK activators designed by Roche

Anti-marinobufagenin antibody studied in salt-sensitive hypertension

Taisho updates pipeline progress for fiscal 2011

Shionogi reviews pipeline progress of fourth quarter of fiscal 2011

Janssen gains Japanese approval for anti-HIV agent

Agilent set to acquire leading cancer diagnostic company

ArQule and Daiichi Sankyo complete patient recruitment in phase III tivantinib study

Ocera obtains CE Mark for Zysa

Half of target patient population recruited in phase III tasquinimod study

ASLAN obtains global rights to Almirall's DHOdehase inhibitor

Pharmaxis submits NDA for Bronchitol

Helix BioPharma receives clearance for European phase III study in low-grade cervical lesions

MRC Technology and Queen Mary University of London enter multiple GPCR collaborations

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...